MGC Pharmaceuticals (ASX:MXC)

MGC Pharmaceuticals (ASX:MXC)

MGC Pharmaceuticals Ltd (ASX: MXC) is an EU-based Biopharma company with many years of technical, clinical and commercial experience in the medical cannabis industry. The company’s founders were key figures in the global medical cannabis industry, and the core business strategy is to develop and supply high-quality cannabinoid-based pharmaceuticals products for the growing demand in the medical markets in Europe, North America and Australasia.

Board and Management


Roby Zomer
Co-Founder and Managing Director

Roby Zomer has more than 10 years of experience in the BioTech and AgroTech sectors running large-scale projects. Mr Zomer joined MGC Pharmaceuticals as Executive Director & CTO in 2015, bringing his extensive business contacts, scientific and engineering skillset. He has been leading MGC’s strategy to ensure its position as a leader in research and development.

Brett Mitchell
Executive Chairman

Brett Mitchell is a corporate finance executive with more than 20 years’ experience in the finance and resources industries. He has been involved in the founding, financing and management of both private and publicly-listed resource companies, and holds executive and non-executive directorship roles. Mr Mitchell holds a Bachelor of Economics from the University of Western Australia and is also a member of the Australian Institute of Company Directors.

Nativ Segev
Founder, Executive-Director and Head of Business Strategy

Nativ Segev was previously the CEO of a leading Israeli medical cannabis company with a large patient base. He has more than 10 years of experience in implementation, legislation and lobbying in the global medical cannabis industry, combined with more than 15 years of experience in various executive roles. He founded MGC Pharmaceuticals in 2015 to expand into international markets and to raise the quality of, and access to, medicinal phytocannabinoid products to patients worldwide.

Ross Walker
Non-Executive Director and Head of Advisory Board

Dr Ross Walker is an eminent practicing cardiologist with more than 35 years’ experience as a clinician. For the past 20 years, he has been focusing on preventative cardiology, and is one of Australia’s leading preventative health experts.

Considered one of the world’s best keynote speakers and life coaches, he is the author of seven best-selling books as well as a health presenter in the Australian media, including regular appearances on the Nine Network’s Today Show, A Current Affair, Sky News and Switzer Business. He also has a weekly radio show on Sydney’s 2UE/ 4BC and 2CC radio, with other regular segments on 2UE, 6PR, 4BC and 3AW.

MGC Pharmaceuticals (ASX:MXC)